Dai Y, Liu M, Zhang Y, et al
Wegovy is the brand-name version of semaglutide approved for weight loss
While these findings remain encouraging, much of the published evidence has been generated through laboratory and animal models, and additional research is needed to further define its biological effects
The distinction matters: Visceral fat drives insulin resistance and cardiovascular risk Lean mass supports metabolic rate, insulin sensitivity, and physical function Muscle preservation is associated with better long-term weight maintenance Published research consistently associates resistance training and adequate protein intake (the International Society of Sports Nutrition recommends 1.42.0 g/kg/day for exercising individuals during energy restriction ISSN Position Stand) with better lean mass preservation during weight loss from any cause
Vallianou NG, Stratigou T, Tsagarakis S
For best practices in a research setting, you should use one syringe for reconstitution and a fresh, sterile syringe (typically an insulin syringe) for drawing each precise dose for your experiment